301
Views
4
CrossRef citations to date
0
Altmetric
REVIEW

Antimicrobial Resistance and Human Mobility

, , ORCID Icon &
Pages 127-133 | Published online: 13 Jan 2022

References

  • Centers for Disease Control and Prevention (U.S.). Antibiotic Resistance Threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.); 2019.
  • European Center for Disease Prevention and Control. Organization for Economic Cooperative Development. Antimicrobial resistance: tackling the burden in the European Union; 2019. Available from: https://www.oecd.org/health/health-systems/AMR-Tackling-the-Burden-in-the-EU-OECD-ECDC-Briefing-Note-2019.pdf. Accessed December 21, 2021.
  • Droz N, Hsia Y, Ellis S, Dramowski A, Sharland M, Basmaci R. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2019;8(1):207. doi:10.1186/s13756-019-0673-5
  • Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-9
  • International Organization for Migration, United Nations Department of Economic and Social Affairs. UN system task team on the post-2015 UN development agenda; May, 2012. Available from: https://www.un.org/millenniumgoals/pdf/Think%20Pieces/13_migration.pdf. Accessed December 21, 2021.
  • Glaesser D, Kester J, Paulose H, Alizadeh A, Valentin B. Global travel patterns: an overview. J Travel Med. 2017;24(4). doi:10.1093/jtm/tax007
  • Tuite AR, Bhatia D, Moineddin R, Bogoch II, Watts AG, Khan K. Global trends in air travel: implications for connectivity and resilience to infectious disease threats. J Travel Med. 2020;27(4):taaa070. doi:10.1093/jtm/taaa070
  • Edmond C. Global migration, by the numbers: who migrates, where they go and why. World Economic Forum; January 10, 2020. Available from: https://www.weforum.org/agenda/2020/01/iom-global-migration-report-international-migrants-2020/. Accessed December 21, 2021.
  • Internal Displacement Monitoring Center. Internal Displacement. Available from: https://www.internal-displacement.org/internal-displacement. Accessed December 21, 2021.
  • Castelli F, Sulis G. Migration and infectious diseases. Clin Microbiol Infect. 2017;23(5):283–289. doi:10.1016/j.cmi.2017.03.012
  • Kraemer MUG, Yang CH, Gutierrez B, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493–497. doi:10.1126/science.abb4218
  • Barnett ED, MacPherson DW, Stauffer WM, et al. The visiting friends or relatives traveler in the 21st century: time for a new definition. J Travel Med. 2010;17(3):163–170. doi:10.1111/j.1708-8305.2010.00411.x
  • Ruppé E, Andremont A, Armand-Lefèvre L. Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: an update. Travel Med Infect Dis. 2018;21:28–35. doi:10.1016/j.tmaid.2017.11.007
  • Furuya-Kanamori L, Stone J, Yakob L, et al. Risk factors for acquisition of multidrug-resistant Enterobacterales among international travellers: a synthesis of cumulative evidence. J Travel Med. 2020;27(1):taz083. doi:10.1093/jtm/taz083
  • Grass JE, Kim S, Huang JY, et al. Quinolone nonsusceptibility among enteric pathogens isolated from international travelers - Foodborne Diseases Active Surveillance Network (FoodNet) and National Antimicrobial Monitoring System (NARMS), 10 United States sites, 2004–2014. PLoS One. 2019;14(12):e0225800. doi:10.1371/journal.pone.0225800
  • Ruppé E, Armand-Lefèvre L, Estellat C, et al. High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis. 2015;61(4):593–600. doi:10.1093/cid/civ333
  • Arcilla MS, van Hattem JM, Haverkate MR, et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17(1):78–85. doi:10.1016/S1473-3099(16)30319-X
  • Worby CJ, Earl AM, Turbett SE, et al. Acquisition and long-term carriage of multidrug-resistant organisms in US international travelers. Open Forum Infect Dis. 2020;7(12):ofaa543. doi:10.1093/ofid/ofaa543
  • Mellon G, Turbett SE, Worby C, et al. Acquisition of antibiotic-resistant bacteria by U.S. international travelers. N Engl J Med. 2020;382(14):1372–1374. doi:10.1056/NEJMc1912464
  • Voor In ’T Holt AF, Mourik K, Beishuizen B, et al. Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors. Antimicrob Resist Infect Control. 2020;9(1):71. doi:10.1186/s13756-020-00733-6
  • Nurjadi D, Olalekan AO, Layer F, et al. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe. J Antimicrob Chemother. 2014;69(9):2361–2368. doi:10.1093/jac/dku174
  • Kuhn KG, Hvass AK, Christiansen AH, Ethelberg S, Cowan SA. Sexual contact as risk factor for Campylobacter infection, Denmark. Emerg Infect Dis. 2021;27(4):1133–1140. doi:10.3201/eid2704.202337
  • Allen H, Mitchell HD, Simms I, et al. Evidence for re-infection and persistent carriage of Shigella species in adult males reporting domestically acquired infection in England. Clin Microbiol Infect. 2021;27(1):126.e7–126.e13. doi:10.1016/j.cmi.2020.03.036
  • Hagmann SHF, Angelo KM, Huits R, et al. Epidemiological and clinical characteristics of international travelers with enteric fever and antibiotic resistance profiles of their isolates: a geosentinel analysis. Antimicrob Agents Chemother. 2020;64(11). doi:10.1128/AAC.01084-20
  • Sridhar S, Turbett SE, Harris JB, LaRocque RC. Antimicrobial-resistant bacteria in international travelers. Curr Opin Infect Dis. 2021;34(5):423–431. doi:10.1097/QCO.0000000000000751
  • Karami Z, Knoop BT, Dofferhoff ASM, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis. 2021;53(2):102–110. doi:10.1080/23744235.2020.1839672
  • Beović B, Doušak M, Ferreira-Coimbra J, et al. Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020;75(11):3386–3390. doi:10.1093/jac/dkaa326
  • Nellums LB, Thompson H, Holmes A, et al. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(7):796–811. doi:10.1016/S1473-3099(18)30219-6
  • Abbara A, Rawson TM, Karah N, et al. Antimicrobial resistance in the context of the Syrian conflict: drivers before and after the onset of conflict and key recommendations. Int J Infect Dis. 2018;73:1–6. doi:10.1016/j.ijid.2018.05.008
  • Karamya ZA, Youssef A, Adra A, et al. High rates of antimicrobial resistance among clinical isolates from microbiology laboratories in Syria. J Infect. 2021;82(2):e8–e10. doi:10.1016/j.jinf.2020.09.026
  • Reinheimer C, Kempf VAJ, Göttig S, et al. Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June‒December 2015. Eurosurveillance. 2016;21(2). doi:10.2807/1560-7917.ES.2016.21.2.30110
  • Hargreaves S, Lönnroth K, Nellums LB, et al. Multidrug-resistant tuberculosis and migration to Europe. Clin Microbiol Infect. 2017;23(3):141–146. doi:10.1016/j.cmi.2016.09.009
  • Walker TM, Merker M, Knoblauch AM, et al. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018;18(4):431–440. doi:10.1016/S1473-3099(18)30004-5
  • Githui WA, Hawken MP, Juma ES, et al. Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis. 2000;4(10):947–955.
  • Eimer J, Patimeteeporn C, Jensenius M, et al. Multidrug-resistant tuberculosis imported into low-incidence countries—a GeoSentinel analysis, 2008–2020. J Travel Med. 2021;28(6):taab069. doi:10.1093/jtm/taab069
  • Long R, Lau A, Egedahl ML, et al. Local transmission plays no important role in the occurrence of multidrug-resistant tuberculosis in immigrants to Canada: an In-depth epidemiologic analysis. J Infect Dis. 2021:jiab045. doi:10.1093/infdis/jiab045.
  • Thomas CM, Morkeberg OH, Walker PF, Stauffer WM. The cost of global connectivity: faster and more efficient spread of antimicrobial resistance by international travelers – a controversial commentary. Travel Med Infect Dis. 2021;41:102045. doi:10.1016/j.tmaid.2021.102045
  • Hu Y, Matsui Y, Riley LW. Risk factors for fecal carriage of drug-resistant Escherichia coli: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):31. doi:10.1186/s13756-020-0691-3
  • Wuerz TC, Kassim SS, Atkins KE. Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: systematic review and meta-analysis. Travel Med Infect Dis. 2020;37:101823. doi:10.1016/j.tmaid.2020.101823
  • International Organization for Migration. Key migration terms. Available from: https://www.iom.int/key-migration-terms. Accessed December 21, 2021.